Moneycontrol PRO
you are here: HomeNewsCovishield
covishield
Jump to
  • COVID-19 shots administered in India about to overtake count in all of Europe, North America Jun 20, 2022 06:09 PM IST

    COVID-19 shots administered in India about to overtake count in all of Europe, North America

    This is a remarkable feat, considering that all the vaccine doses administered in the country are made locally

  • Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin  Jun 06, 2022 01:30 PM IST

    Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin 

    The pharma regulator has approved the first mix-and-match of COVID-19 vaccines in India, but the final say-so lies with the government 

  • World's biggest vaccine maker Serum halts production with 200 million doses spare Apr 23, 2022 09:03 AM IST

    World's biggest vaccine maker Serum halts production with 200 million doses spare

    The Serum Institute has produced more than one billion doses of Covishield -- its version of the AstraZeneca jab -- and is a major supplier to the Covax global inoculation programme for poorer countries.

  • India's 'warm' vaccine candidate effective against Delta, Omicron variants in mice: Study Apr 16, 2022 01:34 PM IST

    India's 'warm' vaccine candidate effective against Delta, Omicron variants in mice: Study

    The heat-tolerant COVID-19 vaccine candidate can be stored at 37 degrees Celsius for four weeks and at 100 degrees Celsius for up to 90 minutes.

  • Reduce time gap for COVID vaccine booster dose to six months: Serum Institute to govt Apr 12, 2022 07:32 PM IST

    Reduce time gap for COVID vaccine booster dose to six months: Serum Institute to govt

    New Delhi, Apr 12 Vaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose..

  • SII to give free Covishield vials to private vaccination centres to compensate for price difference Apr 10, 2022 02:43 PM IST

    SII to give free Covishield vials to private vaccination centres to compensate for price difference

    The inventories at the private CVCs would be verified by SII representatives and the claim would then be processed on the basis of their approval.

  • Moneycontrol Daily: Your Essential 7 Apr 10, 2022 07:30 AM IST

    Moneycontrol Daily: Your Essential 7

    A daily round-up of the most interesting articles to help jump-start the day.

  • Covaxin, Covishield prices slashed to Rs 225 per shot, a day before precaution drive starts Apr 09, 2022 04:38 PM IST

    Covaxin, Covishield prices slashed to Rs 225 per shot, a day before precaution drive starts

    While prices for the Covishield doses were brought down from Rs 600 a shot, Covaxin was slashed from Rs 1,200.

  • For future orders, SII to provide free replacement if vaccine expires: Adar Poonawalla Apr 08, 2022 05:09 PM IST

    For future orders, SII to provide free replacement if vaccine expires: Adar Poonawalla

    "In 10-14 days, Covovax can be available on CoWin at about Rs 900 plus tax," the SII chief executive said.

  • Huge response to COVID-19 shots for 12-14 age group; private hospitals keep away Mar 23, 2022 03:17 PM IST

    Huge response to COVID-19 shots for 12-14 age group; private hospitals keep away

    Private healthcare providers struggling to use up their stocks of Covishield and Covaxin shots are showing no enthusiasm for the Corbevax vaccination of children.

  • Explainer: Intranasal vaccine against COVID-19 and why it is awaited so eagerly Mar 08, 2022 03:54 PM IST

    Explainer: Intranasal vaccine against COVID-19 and why it is awaited so eagerly

    As the efficacy trials of the intranasal COVID-19 vaccine from Bharat Biotech begin this week, there are hopes that if successful, such a vaccine may finally bring the pandemic to an end

  • Adar Poonawalla, CEO of vaccine maker Serum Institute, has a message for Novak Djokovic Feb 18, 2022 07:56 AM IST

    Adar Poonawalla, CEO of vaccine maker Serum Institute, has a message for Novak Djokovic

    Unvaccinated tennis player Novak Djokovic has said that though he is not against COVID-19 vaccines, he will skip tournaments if compelled to take the jab.

  • Piles of unused COVID-19 jabs near expiry, private hospitals turn to government for bailout Feb 08, 2022 01:29 PM IST

    Piles of unused COVID-19 jabs near expiry, private hospitals turn to government for bailout

    As most vaccine beneficiaries prefer to line up at government hospitals, private hospitals now want the government to buy the doses. Of the nearly 175 crore vaccine doses administered, less than 5 percent have been in private hospitals

  • Centre spent Rs 28,436 crore on vaccination this fiscal, leaving 27% of the allocated fund unspent Feb 03, 2022 10:01 AM IST

    Centre spent Rs 28,436 crore on vaccination this fiscal, leaving 27% of the allocated fund unspent

    A sum of Rs 35,000 crore was originally proposed to be spent on COVID vaccination as part of 2021-22 budget which was later revised to Rs 39,000 crore. Response to an RTI query has revealed that the government has spent majority of the amount

  • Economic Survey 2022 | Only 4-5% of Covid-19 vaccine shots administered in private hospitals Jan 31, 2022 05:55 PM IST

    Economic Survey 2022 | Only 4-5% of Covid-19 vaccine shots administered in private hospitals

    Private hospitals were slated to be an important partner in the COVID19 vaccination drive launched in January, 2021 but barring a few initial months, their role in the massive campaign has been negligible as high prices of vaccines at private centres has kept people away.

  • Moneycontrol Daily: Your Essential 7 Jan 28, 2022 07:29 AM IST

    Moneycontrol Daily: Your Essential 7

    A daily round-up of the most interesting articles to help jump-start the day.

  • COVAXIN and Covishield granted regular market approval for use in adult population: Mansukh Mandaviya Jan 27, 2022 02:57 PM IST

    COVAXIN and Covishield granted regular market approval for use in adult population: Mansukh Mandaviya

    The Drugs Controller General of India’s (DCGI) approval came after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on January 19 recommended granting regular market approval to the Serum Institute of India’s (SII’s) Covishield and Bharat Biotech’s Covaxin for use in adult population subject to certain conditions.

  • Each dose of Covishield, Covaxin likely to be capped at Rs 275 after getting regular market approval Jan 26, 2022 03:58 PM IST

    Each dose of Covishield, Covaxin likely to be capped at Rs 275 after getting regular market approval

    According to official sources, the National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines affordable.

  • Expert panel suggests regular market authorisation for Covishield, Covaxin Jan 19, 2022 09:39 PM IST

    Expert panel suggests regular market authorisation for Covishield, Covaxin

    The two COVID-19 vaccines, cumulatively administered to over 90 percent beneficiaries in the country so far, were granted emergency use authorisation in January 2021.

  • 1 year, 156 cr Covid shots, 2 backbone jabs | Recap of India's 'fastest, largest' vaccine drive Jan 16, 2022 03:09 PM IST

    1 year, 156 cr Covid shots, 2 backbone jabs | Recap of India's 'fastest, largest' vaccine drive

    Covishield and Covaxin have held the vaccination drive together over the past year. ZyCoV-D, while having been approved, is yet to be rolled out as India enters the second year of Covid-19 vaccination.

  • What is marketing authorisation that Covishield has applied for? Jan 03, 2022 01:52 PM IST

    What is marketing authorisation that Covishield has applied for?

  • Covovax better booster for Covishield-vaccinated people: Virologist Dec 30, 2021 08:26 AM IST

    Covovax better booster for Covishield-vaccinated people: Virologist

    Dr Shahid Jameel, the former head of the advisory group to the Indian SARS-COV-2 Genomics Consortia (INSACOG), said there is no data for the other combinations of vaccines as of now.

  • Covishield production capacity 250-275 million doses a month, Covaxin 50-60 million: MoS Health Dec 14, 2021 06:08 PM IST

    Covishield production capacity 250-275 million doses a month, Covaxin 50-60 million: MoS Health

    Both companies have achieved close to 90 per cent of present production capacity, Minister of State for Health Bharati Pravin Pawar said in a written reply.

  • COVID-19 | Subject Expert Committee rejects Serum Institute’s application for Covishield booster dose Dec 10, 2021 11:09 PM IST

    COVID-19 | Subject Expert Committee rejects Serum Institute’s application for Covishield booster dose

    The SEC met on December 10 to review the applications made by both Serum Institute, which manufactures Oxford-AstraZeneca’s COVID-19 vaccine Covishield in India, and Biological E which makes Corbevax coronavirus vaccine.

  • SII may cut Covishield's monthly production by half amid demand slump Dec 08, 2021 08:28 AM IST

    SII may cut Covishield's monthly production by half amid demand slump

    SII has written to the government to seek clarity on its requirement, if any, for normal two doses for eligible people in the country and also on booster doses.

Sections
ISO 27001 - BSI Assurance Mark